Kazuyuki Matsui

SBI Asset Management Co., Ltd. (SBI-AM) is the wholly-owned asset management subsidiary of Morningstar Japan KK (NJ: 4765) in Japan. The current firm was established through the 2002 merger of Aozora Asset Management and Softbank Asset Management, both acquired in 2001. SBI-AM provides financial advisory and investment trust management services. They manage conventional investment trusts and discretionary portfolios as well as private equity and alternative investment products. The parent group's culture emphasizes their focus on asset management and their independence from any bank.

Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA.

Uniden Holdings Corp. engages in the development, manufacture, and sale of telecommunications and wireless communications equipment. It operates through the Electronics and Real Estate segments. The Electronics segment offers wireless communication equipment, digital home appliances, and telephone-related devices. The Real Estate segment handles the sale and lease of real estate properties. The company was founded by Hidero Fujimoto on February 7, 1966 and is headquartered in Tokyo, Japan.